Home › NDC Lookup › RxCUI directory › RxCUI 751901

{84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredient... — RxCUI 751901

RxNorm drug concept · Generic pack
RxCUI 751901 Generic pack · GPCK ● Current RxNorm concept 7 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI751901
Official name{84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asEth estra-Levonorgest 0.03-0.15 MG (84) Oral Tablet / Inert 1 MG (7) Oral Tablet 3 Month Pack
FDA products mapped7
Package NDCs mapped7
Reported Medicaid activity (SDUD)38,852 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levonorgestrel: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • They both contain levonorgestrel, but they work very differently. The IUS (like Mirena, Liletta, Kyleena, or Skyla) is a small device a provider places inside your uterus that slow...
  • What's the difference between the IUS and the emergency contraceptive pill — are they the same thing?
  • The sooner the better — you should take it within 72 hours (3 days) of unprotected sex. It becomes less effective the longer you wait, so don't delay. If you vomit within 2 hours o...
  • How quickly do I need to take the emergency contraceptive tablet after sex?
📖 Read our full Levonorgestrel guide →

🕸️ Concept Web — How {84 (ethinyl estradiol 0.03 MG / levonorgestrel... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack RxCUI 751901

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Ethinyl estradiol 4124
    • Inert ingredients 748794
    • Levonorgestrel 6373
    • Ethinyl estradiol / levonorgestrel 214558
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ethinyl estradiol / levonorgestrel Oral Tablet 372590
    • Inert ingredients Oral Tablet 748796
    • Ethinyl estradiol / levonorgestrel Oral Product 1157348
    • Ethinyl estradiol / levonorgestrel Pill 1157349
    • Inert ingredients Oral Product 1156911
    • Inert ingredients Pill 1156912
    • Pack 746839
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  4. Packs 4

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 21 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet SCD · 238019
  • Inert ingredients 1 MG Oral Tablet SCD · 748797
  • Ethinyl estradiol 0.03 MG SCDC · 315897
  • Inert ingredients 1 MG SCDC · 748795
  • Levonorgestrel 0.15 MG SCDC · 316148
  • Ethinyl estradiol / levonorgestrel Oral Tablet SCDF · 372590
  • Inert ingredients Oral Tablet SCDF · 748796
  • Ethinyl estradiol / levonorgestrel Oral Product SCDG · 1157348
  • Ethinyl estradiol / levonorgestrel Pill SCDG · 1157349
  • Inert ingredients Oral Product SCDG · 1156911

Brand-Name Concepts

📦 FDA Products & Package NDCs

7 products · 7 package NDCs
7 package NDCs map to RxCUI 751901 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00555-9123-66 3 POUCH in 1 CARTON (0555-9123-66) / 1 BLISTER PACK in 1 PO... Jolessa Teva Pharmaceuticals USA, Inc. 2003-10-13
16714-0366-03 3 POUCH in 1 CARTON (16714-366-03) / 1 BLISTER PACK in 1 PO... SETLAKIN Northstar Rx LLC 2015-08-01
65862-0865-83 3 POUCH in 1 CARTON (65862-865-83) / 1 BLISTER PACK in 1 PO... Iclevia Aurobindo Pharma Limited 2018-06-29
68180-0843-13 3 BLISTER PACK in 1 CARTON (68180-843-13) / 1 KIT in 1 BLIS... Levonorgestrel and Ethinyl Estradiol Lupin Pharmaceuticals, Inc. 2012-10-24
68462-0672-95 3 POUCH in 1 CARTON (68462-672-95) / 1 BLISTER PACK in 1 PO... levonorgestrel and ethinyl estradiol Glenmark Pharmaceuticals Inc., USA 2015-06-12
70700-0117-87 1 BLISTER PACK in 1 CARTON (70700-117-87) / 1 KIT in 1 BLIS... Introvale Xiromed, LLC. 2018-02-01
70700-0208-88 3 POUCH in 1 CARTON (70700-208-88) / 1 BLISTER PACK in 1 PO... INTROVALE Xiromed LLC 2025-01-29
Observed labelers: Aurobindo Pharma Limited (1) · Glenmark Pharmaceuticals Inc., USA (1) · Lupin Pharmaceuticals, Inc. (1) · Northstar Rx LLC (1) · Teva Pharmaceuticals USA, Inc. (1) · Xiromed LLC (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.